Last updated on August 2018

Survey Study for Velaglucerase Alfa (VPRIV) in Japan


Brief description of study

The objective of this post-marketing survey study is to collect data to determine the safety and efficacy of velaglucerase alfa (VPRIV) in participants with Gaucher disease who are new to therapy or have been switched from another therapeutic agent for Gaucher disease.

Clinical Study Identifier: NCT03625882

Contact Investigators or Research Sites near you

Start Over

Shire Contact

Obihiro
Obihiro, Japan
1.34miles
  Connect »